Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer

NCT06910072 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Triple-Negative Breast Cancer (TNBC)
Neoadjuvant Therapy

Interventions

DRUG: paclitaxel polymeric micelles + carboplatin + iparomilimab and tuvonralimab

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences